Continuing Medical Education Participant Evaluation Form
Thank you for attending this CME/CE activity. Your feedback is essential to improve the quality and effectiveness of our educational programs. Please complete this form honestly.
*
Full Name
*
Mobile No.
*
Job Title
*
Company
*
Reference No. / Confirmation No. / Registration No.
*
Email Address for CME Certificate
*
Section 1: Activity Content
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
1. The learning objectives were clearly stated.
2. The content was relevant to my professional practice.
3. The activity was evidence-based and free from commercial bias.
Section 2: Educational Effectiveness
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
4. The activity increased my knowledge on the topic.
5. The activity will change or reinforce my practice.
6. The teaching methods were effective (e.g., lectures, case discussions, workshops).
Section 3: Speaker/Faculty Evaluation
*
7. The speaker(s) were knowledgeable and well-prepared.
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Baseline Clinical Knowledge Assessment - Part 1 - Dr. Shuayb Elkhalifa
Baseline Clinical Knowledge Assessment - Part 2 - Dr. Hamad Al Hameli
Overview of Type 2 Inflammatory Pathways and Clinical Impact in Lung and Nasal Diseases - Prof. Ian Adcock
Case-Based Discussion: Differentiating Asthma, COPD, and CRSwNP – Where They Overlap? Part 1 - Prof. Ian Adcock
Case-Based Discussion: Differentiating Asthma, COPD, and CRSwNP – Where They Overlap? Part 2 - Dr. Rand K. Arnaout, Dr. Zaid Zoumot, Prof. Naif H. Alotaibi
Clinical Phenotypes and Endotypes in Type 2 Airway Diseases – Biomarkers Focus - Prof. Ibon Eguiluz
My Approach to Severe Asthma: Diagnosing and Phenotyping - Prof. Celeste Porsbjerg
Challenging Cases in Severe Asthma - Prof. Celeste Porsbjerg
Multimorbidity Management – When Asthma Meets CRSwNP and COPD - Prof. Ian Adcock
Case Studies in Group Work 1: Collaborative Management Between ENT, Pulmonology & Allergy - Prof. Maryam Al-Nesf Al-Mansouri, Prof. Ibon Eguiluz, Prof. Naif H. Alotaibi
Case Studies in Group Work 2: Collaborative Management Between ENT, Pulmonology & Allergy - Dr. Iman Nasr, Prof. Ian Adcock, Dr. Mohammed Zeitouni
Biologics in Asthma & CRSwNP: Current Indications & Future Targets - Prof. Ibon Eguiluz
Managing COPD with Type 2 Features – Guiding Through Guidelines - Prof. Celeste Porsbjerg
My Approach to COPD: Treatment Options - Prof. Celeste Porsbjerg
Integrating Imaging in the Evaluation of Upper and Lower Airway Disorders - Dr. Mahmoud Elkaissi
Interpreting Lung Function, CT, and Biomarker Data in Complex Patients - Prof. Celeste Porsbjerg
Workshop A - Part 1: Developing a Treatment Plan for a Patient with Severe Asthma and Nasal Polyps - Prof. Ibon Eguiluz
Workshop A - Part 2: Developing a Treatment Plan for a Patient with Severe Asthma and Nasal Polyps - Dr. Shuayb Elkhalifa, Prof. Naif H. Alotaibi
Workshop B - Part 1: COPD and Type 2 Inflammation – Identifying Candidates for ICS or Biologic Therapy - Prof. Ian Adcock
Workshop B - Part 2: COPD and Type 2 Inflammation – Identifying Candidates for ICS or Biologic Therapy - Prof. Celeste Porsbjerg
The United Airway Concept: Bridging Asthma, COPD, and Nasal Polyposis: Final Thoughts - Prof. Mohamed Abuzakouk, Prof. Celeste Porsbjerg, Prof. Ian Adcock, Prof. Ibon Eguiluz, Prof. Naif H. Alotaibi
8. The speaker(s) presented information in a clear and understandable manner.
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Baseline Clinical Knowledge Assessment - Part 1 - Dr. Shuayb Elkhalifa
Baseline Clinical Knowledge Assessment - Part 2 - Dr. Hamad Al Hameli
Overview of Type 2 Inflammatory Pathways and Clinical Impact in Lung and Nasal Diseases - Prof. Ian Adcock
Case-Based Discussion: Differentiating Asthma, COPD, and CRSwNP – Where They Overlap? Part 1 - Prof. Ian Adcock
Case-Based Discussion: Differentiating Asthma, COPD, and CRSwNP – Where They Overlap? Part 2 - Dr. Rand K. Arnaout, Dr. Zaid Zoumot, Prof. Naif H. Alotaibi
Clinical Phenotypes and Endotypes in Type 2 Airway Diseases – Biomarkers Focus - Prof. Ibon Eguiluz
My Approach to Severe Asthma: Diagnosing and Phenotyping - Prof. Celeste Porsbjerg
Challenging Cases in Severe Asthma - Prof. Celeste Porsbjerg
Multimorbidity Management – When Asthma Meets CRSwNP and COPD - Prof. Ian Adcock
Case Studies in Group Work 1: Collaborative Management Between ENT, Pulmonology & Allergy - Prof. Maryam Al-Nesf Al-Mansouri, Prof. Ibon Eguiluz, Prof. Naif H. Alotaibi
Case Studies in Group Work 2: Collaborative Management Between ENT, Pulmonology & Allergy - Dr. Iman Nasr, Prof. Ian Adcock, Dr. Mohammed Zeitouni
Biologics in Asthma & CRSwNP: Current Indications & Future Targets - Prof. Ibon Eguiluz
Managing COPD with Type 2 Features – Guiding Through Guidelines - Prof. Celeste Porsbjerg
My Approach to COPD: Treatment Options - Prof. Celeste Porsbjerg
Integrating Imaging in the Evaluation of Upper and Lower Airway Disorders - Dr. Mahmoud Elkaissi
Interpreting Lung Function, CT, and Biomarker Data in Complex Patients - Prof. Celeste Porsbjerg
Workshop A - Part 1: Developing a Treatment Plan for a Patient with Severe Asthma and Nasal Polyps - Prof. Ibon Eguiluz
Workshop A - Part 2: Developing a Treatment Plan for a Patient with Severe Asthma and Nasal Polyps - Dr. Shuayb Elkhalifa, Prof. Naif H. Alotaibi
Workshop B - Part 1: COPD and Type 2 Inflammation – Identifying Candidates for ICS or Biologic Therapy - Prof. Ian Adcock
Workshop B - Part 2: COPD and Type 2 Inflammation – Identifying Candidates for ICS or Biologic Therapy - Prof. Celeste Porsbjerg
The United Airway Concept: Bridging Asthma, COPD, and Nasal Polyposis: Final Thoughts - Prof. Mohamed Abuzakouk, Prof. Celeste Porsbjerg, Prof. Ian Adcock, Prof. Ibon Eguiluz, Prof. Naif H. Alotaibi
Section 4: Overall Experience
*
Excellent
Good
Fair
Poor
9. The overall quality of the activity met my expectations.
10. The activity met my professional needs.
11. The activity has impact on improving patient care
*
Yes
No
12. The program was well organized.
13. Would you recommend this activity to your colleagues?
14. Should this program be offered again?
If yes, how often?
Annually
Biannually
Other
Section 5: The Venue
*
Yes
No
15. The venue is accessible to everyone.
*
Yes
No
Not Applicable
16. The venue has available room for delegates who need to stay in.
*
Yes
No
17. The lecture room is conducive for learning experience and equipped with audiovisual components for live and online lectures.
18. The venue offers refreshments and meals.
19. Overall, the venue is suitable for this event.
Section 6: Open-Ended Feedback
*
20. What was the most valuable part of this activity?
*
21. How could this activity be improved?
*
22. What topics would you like to have in the future?
*
23. Additional comments or suggestions:
